SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950133-08-004054
Filing Date
2008-12-12
Accepted
2008-12-12 13:48:45
Documents
6
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A w71916ae10vkza.htm 10-K/A 380399
2 EX-10.32 w71916aexv10w32.htm EX-10.32 41203
3 EX-10.33 w71916aexv10w33.htm EX-10.33 15634
4 EX-10.34 w71916aexv10w34.htm EX-10.34 47077
5 EXHIBIT 31.1 w71916aexv31w1.htm EX-31.1 2398
6 EXHIBIT 31.2 w71916aexv31w2.htm EX-31.2 2418
  Complete submission text file 0000950133-08-004054.txt   490539
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-26770 | Film No.: 081246013
SIC: 2836 Biological Products, (No Diagnostic Substances)